| Health Care Providers & Services Industry | Healthcare Sector | Mr. Erik Andersson CEO | XFRA Exchange | SE0023467162 ISIN |
| DE Country | 3 Employees | - Last Dividend | 5 Dec 2024 Last Split | - IPO Date |
PolarCool AB (publ) is a Sweden-based medical device company, positioned at the forefront of sports medicine technology since its foundation in 2017. Having its headquarters in Lund, Sweden, this innovative company dedicates its resources to the development, marketing, and sales of advanced medical devices aimed at the treatment of concussive and sub-concussive brain injuries. Specializing in products that offer cooling therapy, PolarCool AB targets a niche yet critical aspect of sports medicine. It focuses on providing solutions that cater to teams, sports organizations, and individual athletes, aiming to enhance the safety and recovery processes within the sports industry.
The flagship product of PolarCool AB is the PolarCap System, a state-of-the-art portable cooling device designed for the treatment of concussive and sub-concussive brain injuries. This innovative product leverages cooling therapy to aid in the management and recovery of brain injuries commonly incurred in sports. The PolarCap System is highly regarded for its portability, ease of use, and effectiveness, making it a preferred choice for sports teams, organizations, and athletes looking to maximize safety and minimize recovery times after injury.